Clinical trials

Experts from around the world have developed the first international expert consensus on gene therapy for hereditary hearing loss, stating...

Moderna has announced it will discontinue its congenital cytomegalovirus (cCMV) vaccine clinical development program. Mr Stephane Bancel, Moderna CEO, said...

The strength and impact of hearing research in Australia was highlighted at Macquarie University Hearing’s first Hearing Research Symposium. Led...

British toddler Opal Sandy, aged three, who was born profoundly deaf in both ears, can now hear normally on her...

Innovative research, including a trial investigating hydrogen peroxide for otitis media, and a project to grow inner ear tissue from...

A new international guideline aims to increase public trust in studies using real-world data to investigate the benefit and harms...

A Western Australian research program which is developing a nasal probiotic therapy called Spritz-OM to prevent childhood ear infections has...

Early signs of hearing improvement have been observed in an Australian toddler who received gene therapy for congenital deafness, the...

Neuroscience Research Australia (NeuRA) and falls specialists have developed an app which is the first of its kind in Australia to...

A new study has documented “considerable improvement” in all 10 patients who received one injection of gene therapy for congenital...